Navigation Links
Chicago-Area Infertility Specialist Richard Sherbahn Presents New Research Showing that High AMH levels are Correlated with Better IVF Outcomes
Date:10/25/2013

Gurnee, IL (PRWEB) October 25, 2013

Infertility specialist Richard Sherbahn, MD, recently presented research on how the female partner’s AMH blood levels relates to in vitro fertilization outcome at the annual meeting of the American Society for Reproductive Medicine in Boston, Massachusetts. The study points to the possibility that aggressive ovarian stimulation and augmentation protocols Dr. Sherbahn uses at the Advanced Fertility Center of Chicago bolster the success rates in women under 35.

Dr. Sherbahn studied 786 IVF cycles in women under 35 years old who had ovarian stimulation for IVF. The patients were separated into three groups according to their AMH level. The low group had an AMH of less than 0.6 ng/ml, the middle group had levels between 0.6 and 1.5 and the high group had levels greater than 1.5.

The study compared the percentage of cycle cancellations, the average number of eggs retrieved, and the live birth rate per cycle for the three AMH groups.

Dr. Sherbahn found much higher rates of cycle cancellation in the low AMH group as compared to that seen in the middle group and the high group. The low AMH group had a cancellation rate of 15.1% compared to 3.7% in the middle group and 0.4% in the high group.

The average number of eggs retrieved in the low group was 7.0, in the middle group it was 9.3, and in the high group 14.2.

The surprising finding of this study was that the live birth rate per cycle was not different between the low AMH group and the middle AMH group. The low AMH group had a live birth rate of 43.4% and the middle AMH group had a live birth rate of 43.6% per cycle. This was not significantly different. The high AMH group had a live birth rate of 63.9% per cycle, which was significantly different from both the low and the middle AMH groups.

“We do not know why our live birth success rates were so high in the low AMH group. One question this study raises is whether AMH is an accurate and reliable predictor of ovarian reserve. Perhaps AMH levels may not be as predictive of IVF outcome in young women under 35 years of age,” said Dr. Sherbahn.

In conclusion high AMH levels correlate with a low risk for cycle cancellation, retrieval of more eggs, and high live birth rates with in vitro fertilization. However couples should not be excluded from attempting IVF due to low AMH values alone.

Although women with very low AMH levels are sometimes counselled by fertility doctors not to try IVF treatment due to low success chances, our research suggests that low AMH levels do not predict low IVF success rates in women under 35 years old.

The Advanced Fertility Center of Chicago, with offices in Gurnee and Crystal Lake, Ill., offers advanced reproductive technology services such as in-vitro fertilization (IVF), intracytoplasmic sperm injection, preimplantation genetic diagnosis, egg freezing and egg donation.

The Center specializes in individualized care, and has IVF success rates and egg donation success rates that are above the national averages.

The Center’s web site, advancedfertility.com, offers more than 300 articles on fertility issues and IVF. To schedule an appointment, call 847.662.1818.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11249783.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Studies Linking Environmental Toxins to Infertility Validate Benefits of Fairhaven Health's FertileDetox
2. Baby Dreams Come True Through Facebook for Las Vegas Couples Facing Infertility
3. Pregnancy Miracle™ Reveals Holistic Infertility Cure
4. Pregnancy Miracle Review Reveals Effective Infertility Treatment
5. Pregnancy Miracle Review Reveals Lisa Olson's Efficient Infertility Treatment
6. Herbal Medicine Is a New Option for Treating Female Infertility Caused by Tubal Blockage and Hydrosalpinx, Announces Wuhan Dr. Lee’s TCM Clinic
7. Naturally Combat Intake of BPA and Prevent Infertility with Dr. Bob “The Drugless Doctor”
8. WINFertility Treatment Program Expands to Central/Southern Texas. Program Makes IVF Treatment More Affordable for Patients Without Infertility Insurance Coverage.
9. New Englanders Without IVF Coverage Have a More Affordable Way to Seek Help Through the WINFertility® Treatment Program
10. Reproductive Medicine Associates of New York Now Participating in the WINFertility® Direct-to-Consumer IVF Program
11. Nearly 50 Million Couples Worldwide Report Infertility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... In its newly released Infusion Therapy ... should be used to ensure patient safety when placing an IV catheter. A ... the use of vein visualization technology in patients with difficult venous access or ...
(Date:2/13/2016)... ... February 13, 2016 , ... DDi ... Management Solution Providers list for its expertise in eClinical Solutions. DDi has built ... serve the technology needs of global clients. DDi provides smarter technology for Clinical ...
(Date:2/12/2016)... Seattle, WA, and Washington, DC (PRWEB) , ... ... ... PATH and the Siemens Foundation today announced a new initiative—the Siemens ... technologies for low-resource settings. The partnership will recruit top students from U.S. ...
(Date:2/12/2016)... PA (PRWEB) , ... February 12, 2016 , ... Each ... event will be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 ... can see new therapy products in action, learn more about their chosen field and ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... at Zuckerberg San Francisco General Hospital on April 5-7. The series is a ... create new habits. The workshops cover a broad range of topics, including coaching ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12 2016  OMS Supply, a ... and medical practitioners, announced today the recent launching of ... visitors a variety of features that enhance the user ... surgery supplies. --> ... a fairly new company that started in early 2016, ...
(Date:2/11/2016)... 2016 - Cardiac Marker ... Medicine and Cancer Therapy. - European Point of ... Markets. - Key Diagnostic Testing Markets. - ... in Genetic Testing. - Molecular Diagnostics in Infectious ... Over-the-Counter Diagnostic Products World Markets. - Point of ...
(Date:2/11/2016)... Feb. 11, 2016  Kindred Biosciences, Inc. (NASDAQ: ... improving the lives of pets, today announced the submission ... New Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, ... (KB0120) of Zimeta for the control of pyrexia (fever) ... --> --> The Chemistry, ...
Breaking Medicine Technology: